133 related articles for article (PubMed ID: 25707205)
1. [The role of alterations in the brain signaling systems regulated by insulin, IGF-1 and leptin in the transition of impaired glucose tolerance to overt type 2 diabetes mellitus].
Shpakov AO
Tsitologiia; 2014; 56(11):789-99. PubMed ID: 25707205
[TBL] [Abstract][Full Text] [Related]
2. [THE BRAIN LEPTIN SIGNALING SYSTEM AND ITS FUNCTIONAL STATE IN METABOLIC SYNDROME AND TYPE 2 DIABETES MELLITIS].
Shpakov AO
Zh Evol Biokhim Fiziol; 2016 Mar; 52(2):161-176. PubMed ID: 30695496
[TBL] [Abstract][Full Text] [Related]
3. The impairment of insulin signaling in Alzheimer's disease.
Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
[TBL] [Abstract][Full Text] [Related]
4. Brain insulin signalling in the regulation of energy balance and peripheral metabolism.
Diamant M
Ideggyogy Sz; 2007 Mar; 60(3-4):97-108. PubMed ID: 17451048
[TBL] [Abstract][Full Text] [Related]
5. [The functional state of biogenic amines- and acetylcholine-regulated signaling systems of the brain in diabetes mellitus].
Shpakov AO
Tsitologiia; 2012; 54(6):459-68. PubMed ID: 22997730
[TBL] [Abstract][Full Text] [Related]
6. Diabetes, obesity, and the brain.
Schwartz MW; Porte D
Science; 2005 Jan; 307(5708):375-9. PubMed ID: 15662002
[TBL] [Abstract][Full Text] [Related]
7. Peroxiredoxin 6, a novel player in the pathogenesis of diabetes.
Pacifici F; Arriga R; Sorice GP; Capuani B; Scioli MG; Pastore D; Donadel G; Bellia A; Caratelli S; Coppola A; Ferrelli F; Federici M; Sconocchia G; Tesauro M; Sbraccia P; Della-Morte D; Giaccari A; Orlandi A; Lauro D
Diabetes; 2014 Oct; 63(10):3210-20. PubMed ID: 24947358
[TBL] [Abstract][Full Text] [Related]
8. [FUNCTIONAL ACTIVITY OF THE BRAIN INSULIN SIGNALING SYS TEM IN NORM AND IN TYPE 2 DIABETES MELLITUS].
Shpakov AO
Ross Fiziol Zh Im I M Sechenova; 2015 Oct; 101(10):1103-27. PubMed ID: 26827491
[TBL] [Abstract][Full Text] [Related]
9. [The brain peptidergic signaling systems in diabetes mellitus].
Shpakov AO; Derkach KV
Tsitologiia; 2012; 54(10):733-41. PubMed ID: 23285726
[TBL] [Abstract][Full Text] [Related]
10. Chronic alcohol consumption, type 2 diabetes mellitus, insulin-like growth factor-I (IGF-I), and growth hormone (GH) in ethanol-treated diabetic rats.
Kim SJ; Ju A; Lim SG; Kim DJ
Life Sci; 2013 Nov; 93(21):778-82. PubMed ID: 24084046
[TBL] [Abstract][Full Text] [Related]
11. Osteogenic potential of bone marrow stromal cells derived from streptozotocin-induced diabetic rats.
Zhao YF; Zeng DL; Xia LG; Zhang SM; Xu LY; Jiang XQ; Zhang FQ
Int J Mol Med; 2013 Mar; 31(3):614-20. PubMed ID: 23292283
[TBL] [Abstract][Full Text] [Related]
12. Glucose oxidase induces insulin resistance via influencing multiple targets in vitro and in vivo: The central role of oxidative stress.
Wang X; Gu C; He W; Ye X; Chen H; Zhang X; Hai C
Biochimie; 2012 Aug; 94(8):1705-17. PubMed ID: 22522094
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor I and impaired glucose tolerance.
Dunger D; Yuen K; Ong K
Horm Res; 2004; 62 Suppl 1():101-7. PubMed ID: 15761241
[TBL] [Abstract][Full Text] [Related]
14. [The role of the fat tissue and its hormones in the mechanisms of insulin resistance and the development of type 2 diabetes mellitus].
Klebanova EM; Balabolkin MI; Kreminskaia VM
Klin Med (Mosk); 2007; 85(7):20-7. PubMed ID: 17882804
[TBL] [Abstract][Full Text] [Related]
15. Is "Leptin Resistance" Another Key Resistance to Manage Type 2 Diabetes?
Salazar J; Chávez-Castillo M; Rojas J; Ortega A; Nava M; Pérez J; Rojas M; Espinoza C; Chacin M; Herazo Y; Angarita L; Rojas DM; D'Marco L; Bermudez V
Curr Diabetes Rev; 2020; 16(7):733-749. PubMed ID: 31886750
[TBL] [Abstract][Full Text] [Related]
16. Effects of coffee on type 2 diabetes mellitus.
Akash MS; Rehman K; Chen S
Nutrition; 2014; 30(7-8):755-63. PubMed ID: 24984989
[TBL] [Abstract][Full Text] [Related]
17. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy.
Zhuang HX; Wuarin L; Fei ZJ; Ishii DN
J Pharmacol Exp Ther; 1997 Oct; 283(1):366-74. PubMed ID: 9336345
[TBL] [Abstract][Full Text] [Related]
19. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.
Clemmons DR; Moses AC; Sommer A; Jacobson W; Rogol AD; Sleevi MR; Allan G
Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252
[TBL] [Abstract][Full Text] [Related]
20. Increased Aβ production prompts the onset of glucose intolerance and insulin resistance.
Jiménez-Palomares M; Ramos-Rodríguez JJ; López-Acosta JF; Pacheco-Herrero M; Lechuga-Sancho AM; Perdomo G; García-Alloza M; Cózar-Castellano I
Am J Physiol Endocrinol Metab; 2012 Jun; 302(11):E1373-80. PubMed ID: 22414803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
